Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::UPDATE ON THE IMPLEMENTATION OF THE SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER

Issuer & Securities

Issuer/ Manager: TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Securities: TIANJIN PHARM DA REN TANG GRP - CNE100000924 - T14
Stapled Security: No

Announcement Title: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast: 04-Aug-2026 18:04:01
Status: New
Announcement Sub Title: UPDATE ON THE IMPLEMENTATION OF THE SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER
Announcement Reference: SG260804OTHR25R8
Submitted By (Co./ Ind. Name): Jiao Yan
Designation: Secretary to the Board
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format): UPDATE ON THE IMPLEMENTATION OF THE SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER

Person(s) giving notice: Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer: 04/08/2026

if you are unable to view the above file, please click the link below.

Total size =151K